EdgarLookup

Oaktree Acquisition Corp. III Life Sciences — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Oaktree Acquisition Corp. III Life Sciences filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $1.97M Nov 13, 2025
Q2 2025 Jun 30, 2025 $1.87M Aug 12, 2025
Q3 2025 Jun 30, 2025 $1.87M Nov 13, 2025
Q1 2025 Mar 31, 2025 $1.66M May 14, 2025
Q2 2025 Mar 31, 2025 $1.66M Aug 12, 2025
Q3 2025 Mar 31, 2025 $1.66M Nov 13, 2025
Q3 2025 Sep 30, 2024 ($48.1K) Nov 13, 2025
Q3 2025 Jun 30, 2024 $0 Nov 13, 2025

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($225.6K) Nov 13, 2025
Q2 2025 Jun 30, 2025 ($269.8K) Aug 12, 2025
Q1 2025 Mar 31, 2025 ($444.8K) May 14, 2025
Q3 2025 Sep 30, 2024 ($48.1K) Nov 13, 2025